Douleurs neuropathiques : avancées cliniques

Attal, 2006, EFNS guidelines on pharmacological treatment of neuropathic pain, Eur J Neurol, 13, 1153, 10.1111/j.1468-1331.2006.01511.x Attal, 2008, Neuropathic pain: Are there distinct subtypes depending on the aetiology or anatomical lesion?, Pain, 138, 343, 10.1016/j.pain.2008.01.006 Attal N, Cruccu G, Baron R, et al. (2010). EFNS guidelines on pharmacological treatment of neuropathic pain (2009) revision. Eur J Neurol in press. Backonja, 2009, NGX-4010, a high concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study, Lancet Neurology, 7, 1106, 10.1016/S1474-4422(08)70228-X Bennett, 2007, Using screening tools to identify neuropathic pain, Pain, 127, 199, 10.1016/j.pain.2006.10.034 Bennett, 2001, The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs, Pain, 92, 147, 10.1016/S0304-3959(00)00482-6 Bouhassira, 2004, Development and validation of the Neuropathic Pain Symptom Inventory, Pain, 108, 248, 10.1016/j.pain.2003.12.024 Bouhassira, 2005, Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4), Pain, 114, 29, 10.1016/j.pain.2004.12.010 Bouhassira, 2008, Prevalence of chronic pain with neuropathic characteristics in the general population, Pain, 136, 380, 10.1016/j.pain.2007.08.013 Cruccu, 2007, EFNS guidelines on neurostimulation therapy for neuropathic pain, Eur J Neurol, 14, 952, 10.1111/j.1468-1331.2007.01916.x Cruccu, 2010, EFNS guidelines on neuropathic pain assessment: Revised 2009, Eur J Neurol, 10.1111/j.1468-1331.2010.02969.x Dworkin, 2007, Pharmacologic management of neuropathic pain : evidence-based recommendations, Pain, 132, 237, 10.1016/j.pain.2007.08.033 Dworkin, 2009, Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2), Pain, 144, 35, 10.1016/j.pain.2009.02.007 Freynhagen, 2006, PainDetect: A new screening questionnaire to detect neuropathic components in patients with back pain, Curr Med Res Opin, 22, 1911, 10.1185/030079906X132488 Galer, 1997, Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale, Neurology, 48, 332, 10.1212/WNL.48.2.332 Gilron, 2005, Morphine, gabapentin, or their combination for neuropathic pain, N Engl J Med, 352, 1324, 10.1056/NEJMoa042580 Gilron, 2009, Nortritpyline and gabapentin, alone and in combination for neuropathic pain: A double-blind, randomised controlled crossover trial, Lancet, 374, 1252, 10.1016/S0140-6736(09)61081-3 Gilron, 2010, Assessment of Neuropathic Pain (NP) HAS. (2007). Recommandations sur le diagnostic des lésions nerveuses périphériques, 2007. Hatem S, Attal N, Gautron M, et al. (2009). Relationship between structural lesions of spinal cord sensory tracts and neuropathic pain in syringomyelia patients. Congrès de l’European Federation of the International Association for the Study of Pain, Lisbonne, 7-12 sept. 2009. Jensen, 2006, The pain quality assessment scale: assessment of pain quality in carpal tunnel syndrome, J Pain, 7, 823, 10.1016/j.jpain.2006.04.003 Krause, 2003, Development of a neuropathic pain questionnaire, Clin J Pain, 19, 306, 10.1097/00002508-200309000-00004 Lefaucheur, 2008, Use of repetitive transcrianal magnetic stimulation in pain relief, Expert Rev Neurother, 8, 799, 10.1586/14737175.8.5.799 Lefaucheur, 2009, Motor cortex stimulation for the treatment of refractory peripheral neuropathic pain, Brain, 132, 1463, 10.1093/brain/awp035 Melzack, 1987, The short-form McGill Pain Questionnaire, Pain, 30, 191, 10.1016/0304-3959(87)91074-8 Merskey, 1994 Norrbrink, 2009, Tramadol in neuropathic pain after spinal cord injury: A randomized double blind placebo-controlled trial, Clin J Pain, 25, 177, 10.1097/AJP.0b013e31818a744d Portenoy, 2006, Development and testing of a neuropathic pain screening questionnaire: ID Pain, Curr Med Res Opin, 22, 1555, 10.1185/030079906X115702 Ranoux, 2008, Botulinum toxin a induces direct analgesic effects in neuropathic pain: A double blind placebo controlled study, Ann Neurol, 64, 274, 10.1002/ana.21427 Rauck, 2009, Intrathecal ziconotide for neuropathic pain: A review, Pain Pract, 9, 327, 10.1111/j.1533-2500.2009.00303.x Rog, 2007, Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis, Clin J Pain, 23, 473, 10.1097/AJP.0b013e31805d0c5d Scholz, 2009, A novel tool for the assessment of pain: validation in low back pain, PLoS Med, 6, 10.1371/journal.pmed.1000047 2010, Recommandations de la société française d’étude et de traitement de la douleur. Diagnostic, évaluation et traitement des douleurs neuropathiques, Neurologies Simpson, 2008, Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy, Neurology, 70, 2305, 10.1212/01.wnl.0000314647.35825.9c Torrance, 2007, The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey, J Pain, 7, 281, 10.1016/j.jpain.2005.11.008 Treede, 2008, Neuropathic pain: redefinition and a grading system for clinical and research purposes, Neurology, 70, 1630, 10.1212/01.wnl.0000282763.29778.59 Truini, 2009, Differential involvement of A-delta and A-beta fibres in neuropathic pain related to carpal tunnel syndrome, Pain, 145, 105, 10.1016/j.pain.2009.05.023 Victor, 2008, The dimensions of pain quality: factor analysis of the Pain Quality Assessment Scale, Clin J Pain, 24, 550, 10.1097/AJP.0b013e31816b1058 Vranken J, Hollmann MW, van der Vegt MH, et al. (2010). Duloxetine in patients with central neuropathic pain: A randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain in press. Yuan, 2009, Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial, Neurology, 72, 1473, 10.1212/01.wnl.0000345968.05959.cf